SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 19, 2021
(Exact name of registrant as specified in its charter)
|(State or other jurisdiction|
|4500 Dorr Street, Toledo, Ohio||43615|
|(Address of principal executive offices)||(Zip Code)|
Registrant’s telephone number, including area code: (419) 247-2800
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Name of each exchange
on which registered
|Common stock, $1.00 par value per share||WELL||New York Stock Exchange|
|4.800% Notes due 2028||WELL28||New York Stock Exchange|
|4.500% Notes due 2034||WELL34||New York Stock Exchange|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
On November 19, 2021, Welltower Inc. (the “Company”) issued $500,000,000 aggregate principal amount of the Company’s 2.750% Notes due 2032 (the “Notes”) pursuant to an automatic shelf registration statement of the Company on Form S-3 (File No. 333-255766) filed with the Securities and Exchange Commission on May 4, 2021 (the “Registration Statement”). The Notes were sold pursuant to an Underwriting Agreement, dated as of November 16, 2021, between the Company and Wells Fargo Securities, LLC, J.P. Morgan Securities LLC and Mizuho Securities USA LLC, as representatives of the several underwriters.
The Notes were issued under an Indenture between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”), dated as of March 15, 2010, a form of which was filed with the Registration Statement (the “Indenture”), as supplemented by Supplemental Indenture No. 21 between the Company and the Trustee, dated as of November 19, 2021 (“Supplemental Indenture”). The Notes bear interest at a rate of 2.750% per year, payable semiannually in arrears on January 15 and July 15 of each year, commencing July 15, 2022. The Notes mature on January 15, 2032. The Company intends to use the net proceeds from the sale of the Notes for general corporate purposes, including repayment of debt and investing in health care and seniors housing properties.
The foregoing description of the Indenture, the Supplemental Indenture and the Notes is qualified in its entirety by reference to the Indenture, Supplemental Indenture, and the form of global note, filed herewith as Exhibits 4.1, 4.2, and 4.3, respectively, and incorporated by reference herein.
Financial Statements and Exhibits.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
/s/ Matthew McQueen
|Name: Matthew McQueen|
|Title: Executive Vice President – General|
|Counsel & Corporate Secretary|
Dated: November 19, 2021